Growth Metrics

Mannkind (MNKD) Interest Coverage Ratio Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 79.36%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 29.25%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -16.86%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 40.09%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 53.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 53.04%
Dec 31, 2025 39.27%
Sep 30, 2025 82.25%
Jun 30, 2025 100.31%
Mar 31, 2025 37.87%
Dec 31, 2024 58.20%
Sep 30, 2024 71.15%
Jun 30, 2024 41.78%
Mar 31, 2024 106.37%
Dec 31, 2023 40.50%
Sep 30, 2023 30.25%
Jun 30, 2023 26.71%
Mar 31, 2023 31.33%
Dec 31, 2022 25.74%
Sep 30, 2022 -17.11%
Jun 30, 2022 45.87%
Mar 31, 2022 30.24%
Dec 31, 2021 11.45%
Sep 30, 2021 52.32%
Jun 30, 2021 35.46%
Mar 31, 2021 59.95%
Dec 31, 2020 35.33%
Sep 30, 2020 10.87%
Jun 30, 2020 17.57%
Mar 31, 2020 2.82%
Dec 31, 2019 -41.40%
Sep 30, 2019 -27.55%
Jun 30, 2019 -61.92%
Mar 31, 2019 -68.76%
Dec 31, 2018 46.60%
Sep 30, 2018 -51.22%
Jun 30, 2018 -27.32%
Mar 31, 2018 -58.53%
Dec 31, 2017 -38.11%
Sep 30, 2017 -20.03%
Jun 30, 2017 23.18%
Mar 31, 2017 10.91%
Dec 31, 2016 1.16%
Sep 30, 2016 67.99%
Jun 30, 2016 31.94%
Mar 31, 2016 28.05%
Dec 31, 2015 -219.39%
Sep 30, 2015 20.34%
Jun 30, 2015 27.83%
Mar 31, 2015 34.24%
Dec 31, 2014 20.84%
Sep 30, 2014 15.08%
Jun 30, 2014 -27.64%
Mar 31, 2014 13.35%
Dec 31, 2013 28.91%
Sep 30, 2013 22.99%
Jun 30, 2013 22.16%